Biotech entity
pharma is the sole category represented across all 1 tracked stories. International AIDS Conference is most often covered alongside Gareth Thomas, which appears in 1 of these 1 story. Each carries 6 original sources on average. We currently track 1 Biotech story that mention International AIDS Conference, all published on September 12, 2026.
Last mentioned: 2d ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. International AIDS Conference is most often covered alongside Gareth Thomas, which appears in 1 of these 1 story. Each carries 6 original sources on average. We currently track 1 Biotech story that mention International AIDS Conference, all published on September 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering International AIDS Conference. Shared-story counts are live from our verified record — not editorial picks.
AIDS 2026 in Rio de Janeiro
Thomas and Gabriel join the Tackle HIV campaign on Ipanema Beach to combat stigma around the virus.
Gareth Thomas discloses HIV status
The retired Welsh rugby star publicly announces he is HIV positive and becomes a global advocate for people living with HIV.
Welton Gabriel diagnosed HIV-positive
Gabriel tests positive and contracts a treatment-resistant strain after a partner stopped medication; it takes seven months to achieve control, including a switch from a hepatotoxic first-line drug.
A drug-resistant HIV case reported from AIDS 2026 illustrates how treatment interruption and first-line liver toxicity complicate care — and why tolerability and resistance barriers still define antiretroviral differentiation. For biopharma, stigma-driven non-adherence is an upstream clinical risk that next-generation regimens must engineer around.
International AIDS Conference is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
